Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2,4-dichloro-5-fluoropyrimidine
- Development stage
- Preclinical
- Modality
- Small Molecules
01
Overview
2,4-dichloro-5-fluoropyrimidine (24DC5FP) is a halogenated pyrimidine derivative currently being investigated as a research compound for its potent antibiofilm and antimicrobial properties against *Staphylococcus aureus*. It functions as a multi-target virulence inhibitor by suppressing key regulatory pathways, including the quorum-sensing regulator AgrA, the effector molecule RNAIII, and the SaeR virulence regulator. This suppression leads to a significant reduction in the expression of downstream virulence factors such as alpha-hemolysin (hla) and nuclease nuc1, which in turn diminishes slime production and hemolytic activity. While primarily utilized as a chemical intermediate in the synthesis of various pharmaceuticals, including 5-fluorouracil derivatives and potential kinase inhibitors, recent research (notably a 2024 study) has highlighted its potential as a lead compound for anti-virulence therapy to combat staphylococcal infections and biofilm-associated resistance.
- Other names
- 2,4-Dichloro-5-fluoropyrimidine
02
Targets
Hla (Staphylococcus aureus alpha toxin)Staphylococcus aureus lipoteichoic acid synthesis pathwayagr (Accessory gene regulator system)SaeRS (Staphylococcus aureus SaeRS two-component system)
Beyond the preview
Go deeper on 2,4-dichloro-5-fluoropyrimidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2,4-dichloro-5-fluoropyrimidine.